BIRC5 and neoplasm: IVS confirmed the presence of polyfunctional CD4+ MAGE-specific T cells, as well as reactivity to other tumor antigens PRAME, survivin, HER2 and Wt1 (not seen or tested for in ex-vivo assays) (Figure 4D).